The medications used to treat OCD are primarily antidepressants that increase serotonin activity in the brain. Five medications have FDA approval specifically for OCD, and several others are used when those first options don’t work well enough. OCD typically requires higher doses and longer treatment timelines than depression, so understanding what to expect can make a real difference in sticking with treatment.
FDA-Approved Medications for OCD
Four SSRIs (selective serotonin reuptake inhibitors) and one older tricyclic antidepressant carry FDA approval for OCD:
- Fluoxetine (Prozac), approved for adults and children 7 and older
- Sertraline (Zoloft), approved for adults and children 6 and older
- Fluvoxamine (Luvox), approved for adults and children 8 and older
- Paroxetine (Paxil), approved for adults only
- Clomipramine (Anafranil), approved for adults and children 10 and older
The four SSRIs are almost always tried first because they have fewer side effects than clomipramine. All of them work by making more serotonin available in the brain, which gradually reduces the intensity of obsessive thoughts and the urge to perform compulsions. There’s no strong evidence that one SSRI works dramatically better than another for OCD, so the choice often comes down to side effect profile and what else you’re taking.
Why OCD Doses Are Higher Than Depression Doses
One of the most important things to know about OCD medication is that it often requires significantly higher doses than the same drug would for depression or anxiety. Researchers believe this is because OCD involves differences in how serotonin receptors function, meaning the brain needs a bigger boost in serotonin to see improvement. For example, someone taking sertraline for depression might do well at 100 mg per day, while someone with OCD may need 200 mg or more.
When standard high doses still aren’t enough, some psychiatrists prescribe what are called supratherapeutic doses, going above the usual maximum. In one study of 105 adults with resistant OCD, patients were treated with sertraline up to 650 mg per day, fluoxetine up to 120 mg, escitalopram up to 80 mg, and fluvoxamine up to 600 mg. These doses are well beyond what’s typical and require close monitoring, but they reflect how stubborn OCD can be compared to other conditions treated with the same drugs.
How Long Before Medication Works
OCD medications take significantly longer to kick in than most people expect. You may need up to 12 weeks on an SSRI before noticing any meaningful benefit. That’s twice as long as the timeline typically quoted for depression. This is one of the biggest reasons people stop treatment too early, assuming the medication isn’t working when it simply hasn’t had enough time.
Once you do respond, most people need to stay on medication for at least a year. Stopping too soon carries a high risk of symptoms returning. Your prescriber will generally want to see sustained improvement before discussing any dose reduction, and even then, tapering is gradual.
Clomipramine: Effective but Heavier Side Effects
Clomipramine is the oldest medication approved for OCD and belongs to a different class called tricyclic antidepressants. It’s sometimes more effective than SSRIs, but it comes with a longer list of side effects: drowsiness, dry mouth, constipation, nausea, decreased sexual function, weight changes, and difficulty concentrating are all common. More serious risks include seizures, fast or irregular heartbeat, and difficulty urinating.
Because of this side effect burden, clomipramine is typically reserved for people who haven’t responded to SSRIs. It’s also not recommended as a first choice for adults over 65. Anyone who has recently had a heart attack should not take it, and it cannot be combined with a class of older antidepressants called MAO inhibitors due to dangerous interactions.
When First-Line Medications Don’t Work
Roughly 40 to 60 percent of people with OCD don’t get adequate relief from an SSRI alone. The most common next step is augmentation, meaning a second medication is added on top of the SSRI rather than replacing it. The medications with the strongest evidence for this role are low-dose antipsychotics, used here not for psychosis but to fine-tune dopamine signaling in the brain.
The two best-supported options are aripiprazole and risperidone. Aripiprazole is typically started at 5 mg per day and adjusted up to 10 to 15 mg, and it’s often preferred for people concerned about weight gain or sedation. Risperidone is used at 0.5 to 3 mg per day, doses much lower than what would be prescribed for a psychotic disorder. Both have shown consistent results in clinical trials as add-on treatments.
Olanzapine (2.5 to 10 mg per day) and quetiapine (up to 300 mg per day) are sometimes tried as well, though the evidence behind them is weaker. Olanzapine may be a better fit for people who also have bipolar disorder or severe insomnia. Quetiapine’s track record in OCD studies has been inconsistent, so it’s generally a later option.
Side Effects at Higher Doses
Because OCD often demands higher SSRI doses, side effects can be more noticeable than they would be for someone taking the same drug at a lower dose for depression. The most common issues include nausea, headache, insomnia or excessive sleepiness, sexual side effects like reduced desire or difficulty with orgasm, and digestive problems. Weight changes are possible with some SSRIs, particularly paroxetine.
When antipsychotics are added, the side effect picture shifts. Weight gain and metabolic changes become a concern, especially with olanzapine. Aripiprazole tends to be the most weight-neutral of the group. Sedation is common with quetiapine and olanzapine but less so with aripiprazole and risperidone at low doses. Your prescriber should monitor bloodwork periodically if you’re on an antipsychotic long-term.
Medications for Children With OCD
Four medications carry FDA approval for pediatric OCD, each with a different minimum age: sertraline from age 6, fluoxetine from age 7, fluvoxamine from age 8, and clomipramine from age 10. In practice, sertraline and fluoxetine are the most commonly prescribed for children because they have the most safety data in younger populations. Therapy, specifically a type called exposure and response prevention, is considered equally important and is often started before or alongside medication in children.
Experimental and Off-Label Approaches
For people who haven’t responded to multiple medications, researchers are exploring drugs that work on a completely different brain chemical: glutamate. A single intravenous dose of ketamine, which blocks a specific glutamate receptor, has been shown to rapidly reduce OCD symptoms in unmedicated patients. This was a significant finding because it proved that OCD symptoms can improve through a pathway that doesn’t involve serotonin at all.
Memantine, an oral medication that works on the same receptor as ketamine but more gently, has shown some promise in individual cases. One patient in a clinical trial maintained a 34 percent reduction in OCD symptom scores after six weeks of memantine. However, when researchers looked at the group as a whole (12 patients), the overall results were not statistically significant. These approaches remain experimental and are not part of standard treatment, but they point toward new options for people with severe, treatment-resistant OCD.